Poland - Zamość: Pharmaceutical products

ID

ocds-pyfy63:2020-455874:2020-455874

Buyer

Samodzielny Publiczny Szpital Wojewódzki im. Papieża Jana Pawła II w Zamościu

Date

2020-09-29

Language

PL

Tags

tender

Release in JSON

ID (OCID)

ocds-pyfy63:2020-455874

Releases

2020-09-29 (ocds-pyfy63:2020-455874:2020-455874)
2020-11-02 (ocds-pyfy63:2020-455874:2020-521747)
2020-11-11 (ocds-pyfy63:2020-455874:2020-540266)
2021-02-09 (ocds-pyfy63:2020-455874:2021-066519)

Releases in JSON

Title

Poland - Zamość: Pharmaceutical products

Award criteria

priceOnly

Award criteria details

Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award criteria for item 35:
- Price

Award criteria for item 36:
- Price

Award criteria for item 37:
- Price

Award criteria for item 38:
- Price

Award criteria for item 39:
- Price

Award criteria for item 40:
- Price

Award criteria for item 41:
- Price

Award criteria for item 42:
- Price

Award criteria for item 43:
- Price

Award criteria for item 44:
- Price

Award criteria for item 45:
- Price

Award criteria for item 46:
- Price

Award criteria for item 47:
- Price

Award criteria for item 48:
- Price

Award criteria for item 49:
- Price

Award criteria for item 50:
- Price

Award criteria for item 51:
- Price

Award criteria for item 52:
- Price

Award criteria for item 53:
- Price

Award criteria for item 54:
- Price

Award criteria for item 55:
- Price

Award criteria for item 56:
- Price

Award criteria for item 57:
- Price

Award criteria for item 58:
- Price

Award criteria for item 59:
- Price

Award criteria for item 60:
- Price

Award criteria for item 61:
- Price

Award criteria for item 62:
- Price

Award criteria for item 63:
- Price

Award criteria for item 64:
- Price

Award criteria for item 65:
- Price

Award period

2020-11-03 - ?

Main procurement category

goods

Procurement method

open

Procurement method details

Open procedure

Tender period

2020-09-29 - 2020-11-03

ID

ocds-pyfy63:2020-455874:obj:1

Classification

CPV / 33600000

Description

Poz. 1–5 – Fluorouracyl – 900 op., poz. 2–5 – Fluorouracyl – 100 op.

ID

ocds-pyfy63:2020-455874:obj:2

Classification

CPV / 33600000

Description

Nab-paclitaxel – 400 op.

ID

ocds-pyfy63:2020-455874:obj:3

Classification

CPV / 33600000

Description

Netupitant, palonosetron hydrochloride – 20 op.

ID

ocds-pyfy63:2020-455874:obj:4

Classification

CPV / 33600000

Description

Cytarabina – 30 op.

ID

ocds-pyfy63:2020-455874:obj:5

Classification

CPV / 33600000

Description

Anagrelidum – 40 op.

ID

ocds-pyfy63:2020-455874:obj:6

Classification

CPV / 33600000

Description

Darbepoetyna alfa – 80 op.

ID

ocds-pyfy63:2020-455874:obj:7

Classification

CPV / 33600000

Description

Poz. 1 – Bewacizumab – 300 op., poz. 2 – Bewacizumab – 300 op.

ID

ocds-pyfy63:2020-455874:obj:8

Classification

CPV / 33600000

Description

Bicalutamid – 20 op.

ID

ocds-pyfy63:2020-455874:obj:9

Classification

CPV / 33600000

Description

Bicalutamid – 20 op.

ID

ocds-pyfy63:2020-455874:obj:10

Classification

CPV / 33600000

Description

Bleomycyna – 150 op.

ID

ocds-pyfy63:2020-455874:obj:11

Classification

CPV / 33600000

Description

Doksorubicyna liposomalna pegylowana – 150 op.

ID

ocds-pyfy63:2020-455874:obj:12

Classification

CPV / 33600000

Description

Poz. 1 – kwas folinowy – 500 op., poz. 2 – kwas folinowy – 150 op.

ID

ocds-pyfy63:2020-455874:obj:13

Classification

CPV / 33600000

Description

Poz. 1 – Kapecytabina – 350 op., poz. 2 – Kapecytabina – 50 op.

ID

ocds-pyfy63:2020-455874:obj:14

Classification

CPV / 33600000

Description

Poz. 1 – Karboplatyna – 300 op., poz. 2 – Karboplatyna – 300 op., poz. 3 – Karboplatyna – 150 op.

ID

ocds-pyfy63:2020-455874:obj:15

Classification

CPV / 33600000

Description

Cisplatyna – 900 op.

ID

ocds-pyfy63:2020-455874:obj:16

Classification

CPV / 33600000

Description

Poz. 1 – Dakarbazyna – 13 op., poz. 2 – Dakarbazyna – 15 op., poz. 3 – Dakarbazyna – 20 op.

ID

ocds-pyfy63:2020-455874:obj:17

Classification

CPV / 33600000

Description

Dexamethasone phosphate – 100 op.

ID

ocds-pyfy63:2020-455874:obj:18

Classification

CPV / 33600000

Description

Poz. 1 – Docetaksel – 300 op., poz. 2 – Docetaksel – 100 op.

ID

ocds-pyfy63:2020-455874:obj:19

Classification

CPV / 33600000

Description

Doksorubicyna – 400 op.

ID

ocds-pyfy63:2020-455874:obj:20

Classification

CPV / 33600000

Description

Poz. 1 – Cyklofosfamid – 460 op., poz. 2 – Cyklofosfamid – 60 op.

ID

ocds-pyfy63:2020-455874:obj:21

Classification

CPV / 33600000

Description

Cyklofosfamid – 20 op.

ID

ocds-pyfy63:2020-455874:obj:22

Classification

CPV / 33600000

Description

Wedolizumab – 20 op.

ID

ocds-pyfy63:2020-455874:obj:23

Classification

CPV / 33600000

Description

Poz. 1 – Epirubicyna – 120 op., poz. 2 – Epirubicyna – 80 op.

ID

ocds-pyfy63:2020-455874:obj:24

Classification

CPV / 33600000

Description

Poz. 1 – Cetuximab – 500 op., poz. 2 – Cetuximab – 320 op.

ID

ocds-pyfy63:2020-455874:obj:25

Classification

CPV / 33600000

Description

Poz. 1 – Etopozyd – 400 op., poz. 2 – Etopozyd – 100 op.

ID

ocds-pyfy63:2020-455874:obj:26

Classification

CPV / 33600000

Description

Fulvestrant – 220 op.

ID

ocds-pyfy63:2020-455874:obj:27

Classification

CPV / 33600000

Description

Infliximab – 130 op.

ID

ocds-pyfy63:2020-455874:obj:28

Classification

CPV / 33600000

Description

Poz. 1 – Gemcytabina – 150 op., poz. 2 – Gemcytabina – 280 op.

ID

ocds-pyfy63:2020-455874:obj:29

Classification

CPV / 33600000

Description

Afatynib – 50 op.

ID

ocds-pyfy63:2020-455874:obj:30

Classification

CPV / 33600000

Description

Trastuzumab – 230 op.

ID

ocds-pyfy63:2020-455874:obj:31

Classification

CPV / 33600000

Description

Poz. 1 – Trastuzumab – 300 op., poz. 2 – Trastuzumab – 100 op.

ID

ocds-pyfy63:2020-455874:obj:32

Classification

CPV / 33600000

Description

Poz. 1 – Ifosfamid – 40 op., poz. 2 – Ifosfamid – 40 op.

ID

ocds-pyfy63:2020-455874:obj:33

Classification

CPV / 33600000

Description

Palbocyclib – 12 op.

ID

ocds-pyfy63:2020-455874:obj:34

Classification

CPV / 33600000

Description

Poz. 1 – Irinotecan hydrochloridum – 400 op., poz. 2 – Irinotecan hydrochloridum – 250 op., poz. 3 – Irinotecan hydrochloridum – 300 op.

ID

ocds-pyfy63:2020-455874:obj:35

Classification

CPV / 33600000

Description

Poz. 1 – Trastuzumab emtanzyna – 100 op., poz. 2 – Trastuzumab emtanzyna – 20 op.

ID

ocds-pyfy63:2020-455874:obj:36

Classification

CPV / 33600000

Description

Pembrolizumab – 130 op.

ID

ocds-pyfy63:2020-455874:obj:37

Classification

CPV / 33600000

Description

Acidum levofolinicum – 200 op.

ID

ocds-pyfy63:2020-455874:obj:38

Classification

CPV / 33600000

Description

Trifluridine, Tipiracil hydrochloride – 40 op.

ID

ocds-pyfy63:2020-455874:obj:39

Classification

CPV / 33600000

Description

Trifluridine, Tipiracil hydrochloride – 15 op.

ID

ocds-pyfy63:2020-455874:obj:40

Classification

CPV / 33600000

Description

Trifluridine, Tipiracil hydrochloride – 20 op.

ID

ocds-pyfy63:2020-455874:obj:41

Classification

CPV / 33600000

Description

Trifluridine, Tipiracil hydrochloride – 40 op.

ID

ocds-pyfy63:2020-455874:obj:42

Classification

CPV / 33600000

Description

Poz. 1 – Rituximab – 30 op., poz. 2 – Rituximab – 70 op.

ID

ocds-pyfy63:2020-455874:obj:43

Classification

CPV / 33600000

Description

Rituximab – 50 op.

ID

ocds-pyfy63:2020-455874:obj:44

Classification

CPV / 33600000

Description

Poz. 1 – Metotrexat – 10 op., poz. 2 – Metotrexat – 30 op.

ID

ocds-pyfy63:2020-455874:obj:45

Classification

CPV / 33600000

Description

Mitomicyna – 10 op.

ID

ocds-pyfy63:2020-455874:obj:46

Classification

CPV / 33600000

Description

Mitoxantron – 10 op.

ID

ocds-pyfy63:2020-455874:obj:47

Classification

CPV / 33600000

Description

Vinorelbina – 600 op.

ID

ocds-pyfy63:2020-455874:obj:48

Classification

CPV / 33600000

Description

Poz. 1 – Vinorelbina – 60 op., poz. 2 – Vinorelbina – 40 op.

ID

ocds-pyfy63:2020-455874:obj:49

Classification

CPV / 33600000

Description

Ondansetron – 1 500 op.

ID

ocds-pyfy63:2020-455874:obj:50

Classification

CPV / 33600000

Description

Poz. 1 – Nivolumab – 300 op., poz. 2 – Nivolumab – 150 op.

ID

ocds-pyfy63:2020-455874:obj:51

Classification

CPV / 33600000

Description

Poz. 1 – Oxaliplatyna – 500 op., poz. 2 – Oxaliplatyna – 400 op.

ID

ocds-pyfy63:2020-455874:obj:52

Classification

CPV / 33600000

Description

Poz. 1 – Paclitaxel – 240 op., poz. 2 – Paclitaxel – 280 op.

ID

ocds-pyfy63:2020-455874:obj:53

Classification

CPV / 33600000

Description

Poz. 1 – Pemetrexed – 140 op., poz. 2 – Pemetrexed – 40 op.

ID

ocds-pyfy63:2020-455874:obj:54

Classification

CPV / 33600000

Description

Pertuzumab – 120 op.

ID

ocds-pyfy63:2020-455874:obj:55

Classification

CPV / 33600000

Description

Oktreotyd – 20 op.

ID

ocds-pyfy63:2020-455874:obj:56

Classification

CPV / 33600000

Description

Lanreotyd – 12 op.

ID

ocds-pyfy63:2020-455874:obj:57

Classification

CPV / 33600000

Description

Atezolizumab – 40 op.

ID

ocds-pyfy63:2020-455874:obj:58

Classification

CPV / 33600000

Description

Poz. 1 – Temozolomid – 700 op., poz. 2 – Temozolomid – 700 op.

ID

ocds-pyfy63:2020-455874:obj:59

Classification

CPV / 33600000

Description

Poz. 1 – Topotekan – 50 op., poz. 2 – Topotekan – 20 op.

ID

ocds-pyfy63:2020-455874:obj:60

Classification

CPV / 33600000

Description

Mesna – 30 op.

ID

ocds-pyfy63:2020-455874:obj:61

Classification

CPV / 33600000

Description

Poz. 1 – Panitumumab – 45 op., poz. 2 – Panitumumab – 40 op.

ID

ocds-pyfy63:2020-455874:obj:62

Classification

CPV / 33600000

Description

Vinkrystyna – 130 op.

ID

ocds-pyfy63:2020-455874:obj:63

Classification

CPV / 33600000

Description

Poz. 1 – Aflibercept – 20 op., poz. 2 – Aflibercept – 20 op.

ID

ocds-pyfy63:2020-455874:obj:64

Classification

CPV / 33600000

Description

Adalimumab – 15 op.

ID

ocds-pyfy63:2020-455874:obj:65

Classification

CPV / 33600000

Description

Poz. 1 – Filgrastym – 600 op., poz. 1 – Filgrastym – 250 op.

Roles

buyer

Organization name

Samodzielny Publiczny Szpital Wojewódzki im. Papieża Jana Pawła II w Zamościu

Street address

Al. Jana Pawła II 10

Locality

Zamość

Postal code

22-400

Country

PL

Contact name

Agata Bosiak

E-mail

zamowienia@szpital.zam.pl

Phone

+48 846773229

Fax

+48 846386669

Website

Link

Organization data Organization in JSON